BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22865898)

  • 21. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
    Vestergaard P; Hermann AP; Orskov H; Mosekilde L
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2286-90. PubMed ID: 10404791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
    Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
    Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
    Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
    Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
    Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
    Mirza FS; Padhi ID; Raisz LG; Lorenzo JA
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1991-7. PubMed ID: 20156921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in circulating sclerostin at the early stage of menopausal transition in Japanese women.
    Matsui S; Yasui T; Kasai K; Keyama K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
    Maturitas; 2016 Jan; 83():72-7. PubMed ID: 26508082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.
    Hinton PS; Nigh P; Thyfault J
    Bone; 2017 Mar; 96():85-90. PubMed ID: 27744012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
    Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
    J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of bone turnover markers in healthy premenopausal women.
    Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
    Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.
    Durosier C; van Lierop A; Ferrari S; Chevalley T; Papapoulos S; Rizzoli R
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3873-83. PubMed ID: 23864703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
    van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
    J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
    Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
    Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum sclerostin levels and metabolic bone diseases].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2013 Jun; 23(6):877-83. PubMed ID: 23719501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical activity and bone turnover markers: a cross-sectional and a longitudinal study.
    Adami S; Gatti D; Viapiana O; Fiore CE; Nuti R; Luisetto G; Ponte M; Rossini M;
    Calcif Tissue Int; 2008 Dec; 83(6):388-92. PubMed ID: 18949504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression.
    Petronijević M; Petronijević N; Ivković M; Stefanović D; Radonjić N; Glisić B; Ristić G; Damjanović A; Paunović V
    Bone; 2008 Mar; 42(3):582-90. PubMed ID: 18226593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
    Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.